Rosanna Coppo, Graziella D'Arrigo, Giovanni Tripepi, Maria Luisa Russo, Ian S D Roberts, Shubha Bellur, Daniel Cattran, Terence H Cook, John Feehally, Vladimir Tesar, Dita Maixnerova, Licia Peruzzi, Alessandro Amore, Sigrid Lundberg, Anna Maria Di Palma, Loreto Gesualdo, Francesco Emma, Cristiana Rollino, Manuel Praga, Luigi Biancone, Antonello Pani, Sandro Feriozzi, Rosaria Polci, Jonathan Barratt, Lucia Del Vecchio, Francesco Locatelli, Alessandro Pierucci, Yasar Caliskan, Agnieszka Perkowska-Ptasinska, Magdalena Durlik, Elisabetta Moggia, José C Ballarin, Jack F M Wetzels, Dimitris Goumenos, Marios Papasotiriou, Kresimir Galesic, Luka Toric, Aikaterini Papagianni, Maria Stangou, Luisa Benozzi, Stefano Cusinato, Ulla Berg, Rezan Topaloglu, Milena Maggio, Mai Ots-Rosenberg, Marco D'Amico, Colin Geddes, Olga Balafa, Marco Quaglia, Raffaella Cravero, Calogero Lino Cirami, Bengt Fellstrom, Jürgen Floege, Jesus Egido, Francesca Mallamaci, Carmine Zoccali
Background: It is unknown whether renal pathology lesions in immunoglobulin A nephropathy (IgAN) correlate with renal outcomes over decades of follow-up. Methods: In 1130 patients of the original Validation Study of the Oxford Classification for IgA Nephropathy (VALIGA) cohort, we studied the relationship between the MEST score (mesangial hypercellularity, M; endocapillary hypercellularity, E; segmental glomerulosclerosis, S; tubular atrophy/interstitial fibrosis, T), crescents (C) and other histological lesions with both a combined renal endpoint [50% estimated glomerular filtration rate (eGFR) loss or kidney failure] and the rate of eGFR decline over a follow-up period extending to 35 years [median 7 years (interquartile range 4...
November 9, 2018: Nephrology, Dialysis, Transplantation